Team : Factors of persistence of leukemic cells - Canther
Next generation sequencing identifies smoldering multiple myeloma patients with a high risk of disease progression - ecancer
Pr Salomon MANIER - Auteur | Edimark
L'ARC soutient les recherches menées à l'IRCL - IRCL
IACH Journal Club – International Academy for Clinical Hematology (IACH)
Salomon Manier | Videos & Research | VJHemOnc
Première mondiale au CHU de Lille dans le traitement du cancer de la moelle osseuse - CHU Lille
Molecular prognostication in SMM | VJHemOnc
Salomon MANIER, auteur sur Horizons Hémato
Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT | Bone Marrow Transplantation
Primary refractory young myeloma: a difficult clinical situation - YouTube
Myeloma Crowd Radio: Irene Ghobrial, MD & Salomon Manier, MD, PhD, Dana Farber 09/27 by HealthTree Podcast for MM | Health
Salomon Manier
Determining the optimal sequencing of bispecifics and CAR-T cells in patients with myeloma - YouTube
ide-cel and neurotoxicity | Int'l Myeloma Foundation
GLS1 dependency in MYC over-expressing multiple myeloma: New target for therapy? - ecancer
Paroles d'expert e UH12 Salomon MANIER 01 720p diagnostic Amylose EM 47692 - YouTube
ASH 2022: Multiple Myeloma Highlights - The ASCO Post
JNM2022 les traitements de la rechute - YouTube
Multiple Myeloma Hub on X: "#EHA2023 | Salomon Manier @CHU_Lille shares efficacy and safety data on BCMA targeted drugs: CAR T, bispecifics and antibody-drug conjugates. Future directions of CAR T cells include
Un médecin de Lille reçoit 50 000 euros pour ses recherches contre le cancer de la moelle osseuse | Lille Actu
ide-cel and neurotoxicity | Int'l Myeloma Foundation
Première mondiale au CHU de Lille dans le traitement du cancer de la moelle osseuse - CHU Lille
☎️ Contacts du Dr Salomon Manier, Hematologue à Lille 59000
ide-cel and neurotoxicity | Int'l Myeloma Foundation
